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Methods

Background

• During rapid sequence intubation (RSI)
providing adequate paralysis while reducing
potential undersedation can be difficult in an
obese patient population.
• There are no guideline recommended dosing
strategies for the use of rocuronium for rapid
sequence intubation in the emergency
department (ED) in the obese patient
population.
• Currently, dosing remains dependent on
practitioner preference. Dosing can be based on
total body weight (TBW), ideal body weight
(IBW), lean body weight (LBW), or adjusted
body weight (aBW).
• A paucity of data have compared the use of
rocuronium in obese patients based on different
body weights.1,3
• It was concluded that the use of ideal or lean
body weight provided sufficient intubation
conditions without prolonging duration of
action1,3.
• However, these studies took place in a surgical
setting and not in the ED, therefore,
demonstrating the need for more data in an
emergency department setting.1,3

Objective

• To evaluate the use of IBW versus TBW
rocuronium dosing in obese patients for rapid
sequence intubation in the emergency
department.

Study Design

Results
IBW is calculated /
TBW is obtained
using either
standard ED
process or review of
prior documentation
in patients' charts.

Rocuronium is
dosed
according to
provider
discretion.

After intubation,
the physician is
asked to complete
a 9-point survey
to assess
intubation
conditions.

INCLUSION CRITERIA

EXCLUSION CRITERIA

Intubated in the emergency
department at ACMC

Age less than 18 years old

Use of rocuronium

Known neuromuscular disease

Obese: total body weight >30%
Allergy or sensitivity to study drug
of ideal body weight or BMI >30

OUTCOME
Primary Outcome:

Optimal intubation conditions
Efficacy: Duration of paralysis

Safety:
Secondary Outcomes:
Incidence of post-intubation hypertension
Incidence of post-intubation tachycardia
Excellent

Results
29.7%

67.9%

70.3%

Good

Poor

26%

6.7%

• Single-center, prospective, observational study
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Non-Inferiority Analysis

Relative Risk
1.05

Excellent

Good

Poor

Limit [90% CI]
0.88 [0.75-1.40]

First Pass Success

p-value
0.19

Duration of paralysis: Time to muscle recovery (min) [IQR]

TBW [N = 49]
71 [57-96]

IBW [N = 33]
43 [40 – 60]

p-value
<0.01

Incidence of Post-Intubation Hypertension

TBW
43.4%

IBW
27.0%

p-value
0.11

Incidence of Post-Intubation Tachycardia

TBW
35.9%

IBW
37.8%

p-value
0.85

Limitations

• Observational, single-centered study
• Intubating physicians' level of experience
• Total body weight may have been based
on estimated weight
• Dosing classification interpreted
• Duration of paralysis based on subjective
nature of observation

Conclusion

• Ideal body weight dosing of rocuronium
is suggested to be non-inferior to total
body weight dosing in obese patients
that require rapid sequence intubation in
the emergency department.
• This sample size demonstrates similar
efficacy of intubation conditions with
shorter duration of paralysis between the
two dosing weight strategies.

• Follow-up superiority studies are
TBW N [%]
IBW N [%]
p-value
suggested with a larger patient
population
to
determine
if
there
is
a
49
[92.5%]
31
[83.8%]
0.2
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